ETH-615

• Description :

  ETH-615 is a 5-lipoxygenase inhibitor. ETH-615 can be used in the research of cardiovascular diseases[1].

• UNSPSC :

  12352005

• Target :

  Lipoxygenase

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Cardiovascular Disease

• Smiles :

  O=C(O)C1=CC=C(CN(CC2=CC=CC(F)=C2)C3=CC=C(OCC4=NC5=CC=CC=C5C=C4)C=C3)C=C1

• Molecular Formula :

  C31H25FN2O3

• Molecular Weight :

  492.54

• References & Citations :

  [1]Naser Ahmadi, et al. Methods for treating cardiovascular diseases. WO2014031586A2. WIPO (PCT) . 2013-08-20.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• Isoform :

  5-LOX

• CAS Number :

  [133430-69-0]